The Journal of General Physiology
VISIT JCB ONLINE!
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 13 September 2004 doi:10.1085/jgp.200409041
The Rockefeller University Press, 0022-1295 $8.00
JGP, Volume 124, Number 4, 301-317
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 842K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JGP
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Ferreiro, R. E.
Right arrow Articles by Pardo, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Ferreiro, R. E.
Right arrow Articles by Pardo, L. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole

Rafael E. García-Ferreiro1, Daniel Kerschensteiner1,2, Felix Major3, Francisco Monje1, Walter Stühmer1, and Luis A. Pardo1

1 Abteilung Molekulare Biologie Neuronaler Signale, Max-Planck Institut für Experimentelle Medizin, 37075 Göttingen, Germany
2 Neurologische Universitätsklinik, 37075 Göttingen, Germany
3 Institut für Organische und Biomolekulare Chemie der Georg-August-Universität, 37077 Göttingen, Germany

Address correspondence to Rafael E. García-Ferreiro, Abteilung Molekulare Biologie Neuronaler Signale, Max-Planck Institut für Experimentelle Medizin, Herman-Rein Strasse 3, 37075 Göttingen, Germany. Fax: 49-551-3899-644; email: rgarcia{at}gwdg.de

Ether à go-go (Eag; KV10.1) voltage-gated K+ channels have been detected in cancer cell lines of diverse origin and shown to influence their rate of proliferation. The tricyclic antidepressant imipramine and the antihistamine astemizole inhibit the current through Eag1 channels and reduce the proliferation of cancer cells. Here we describe the mechanism by which both drugs block human Eag1 (hEag1) channels. Even if both drugs differ in their affinity for hEag1 channels (IC50s are ~2 µM for imipramine and ~200 nM for astemizole) and in their blocking kinetics, both drugs permeate the membrane and inhibit the hEag1 current by selectively binding to open channels. Furthermore, both drugs are weak bases and the IC50s depend on both internal an external pH, suggesting that both substances cross the membrane in their uncharged form and act from inside the cell in their charged forms. Accordingly, the block by imipramine is voltage dependent and antagonized by intracellular TEA, consistent with imipramine binding in its charged form to a site located close to the inner end of the selectivity filter. Using inside- and outside-out patch recordings, we found that a permanently charged, quaternary derivative of imipramine (N-methyl-imipramine) only blocks channels from the intracellular side of the membrane. In contrast, the block by astemizole is voltage independent. However, as astemizole competes with imipramine and intracellular TEA for binding to the channel, it is proposed to interact with an overlapping intracellular binding site. The significance of these findings, in the context of structure–function of channels of the eag family is discussed.

Key Words: open channel blockade • potassium channel • ether à go-go • N-methyl-imipramine • pH dependence


Abbreviation used in this paper: QA, quaternary ammonium.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Gomez-Varela, E. Zwick-Wallasch, H. Knotgen, A. Sanchez, T. Hettmann, D. Ossipov, R. Weseloh, C. Contreras-Jurado, M. Rothe, W. Stuhmer, et al.
Monoclonal Antibody Blockade of the Human Eag1 Potassium Channel Function Exerts Antitumor Activity
Cancer Res., August 1, 2007; 67(15): 7343 - 7349.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Su, Y. Ohno, C. Lossin, H. Hibino, A. Inanobe, and Y. Kurachi
Inhibition of Astroglial Inwardly Rectifying Kir4.1 Channels by a Tricyclic Antidepressant, Nortriptyline
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 573 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. L. Wladyka and D. L. Kunze
KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons
J. Physiol., August 15, 2006; 575(1): 175 - 189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Weber, F. M. de Queiroz, B. R. Downie, A. Suckow, W. Stuhmer, and L. A. Pardo
Silencing the Activity and Proliferative Properties of the Human EagI Potassium Channel by RNA Interference
J. Biol. Chem., May 12, 2006; 281(19): 13030 - 13037.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-B. Yang, F. Major, L. F. Tietze, and M. Rupnik
Block of Delayed-Rectifier Potassium Channels by Reduced Haloperidol and Related Compounds in Mouse Cortical Neurons
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 352 - 362.
[Abstract] [Full Text] [PDF]



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents